Article
Roche hails 'excellent uptake' of Eylea rival Vabysmo as it lauds consumers switching from its competitor
Rating:
0.0
Views:
59
Likes:
1
Library:
1
Roche is hyping up the early financials coming in for its eye disease therapy Vabysmo as the Swiss major looks to take on the might of Regeneron and Bayer's major blockbuster, Eylea. | Roche is hyping up the early financials coming in for its eye disease therapy Vabysmo as the Swiss major looks to take on the might of Regeneron and Bayer's major blockbuster, Eylea.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value